Advertisement

Tabebuia avellanedae Lorentz ex Griseb.

  • Rainer W. BussmannEmail author
Chapter
Part of the Medicinal and Aromatic Plants of the World book series (MAPW, volume 5)

Abstract

Tabebuia avellanedae Lorentz ex Grieseb. (Lapacho, Pau’d’Arco), has long been reported as used in traditional medicine in Central and Latin America for disorders as varied as leishmaniasis, bacterial infections, fever, malaria and syphilis. In the early 1960 reports of cancer being cured with Lapacho extract appeared in Brazil. The taxonomy of the genus Tabebuia is however complicated, and various species are used interchangeably in traditional medicine. At least Tabebuia serratifolia (Vahl) Nichols has to be seen as bioequivalent to T. avellanedae. Lapacho bark is the crude drug, in most cases prepared as infusion or tea. Lapachol and ß-Lapachol are recognized as the main bioactive compounds, and a large number of studies have focused on the anti-tumor, anti-bacterial and anti-inflammatory activity. However, so far little conclusive evidence for efficacy could be provided. The main problem of many studies had been the lack of exact taxonomic identification of the source material, the use of the wrong plant parts, and a focus of very few compounds, rather than traditional preparations. Much more research is needed to assess the actual efficacy of Tabebuia preparations.

Keywords

Lapacho Pau’d’Arco Tabebuia avellanedae Tabebuia serratifolia Bignoniaceae 

References

  1. Awale S, Kawakami T, Tezuka Y, Ueda JY, Tanaka K, Kadota S (2005) Nitric oxide (NO) production inhibitory constituents of Tabebuia avellanedae from Brazil. Chem Pharm Bull (Tokyo) 53(6):710–713CrossRefGoogle Scholar
  2. Böhler T, Nolting J, Gurragchaa P, Lupescu A, Neumayer HH, Budde K, Kamar N, Klupp J (2008) Tabebuia avellanedae extracts inhibit IL-2-independent T- lymphocyte activation and proliferation. Transpl Immunol 18(4):319–323CrossRefGoogle Scholar
  3. Boom B (1990) Useful plants of the Panare Indians of the Venezuelan Guyana. Adv Econ Bot 8:57–76Google Scholar
  4. Byeon SE, Chung JY, Lee YG, Kim BH, Kim KH, Cho JY (2008) In vitro and in vivo anti-inflammatory effects of taheebo, a water extract from the inner bark of Tabebuia avellanedae. J Ethnopharmacol 119(1):145–152CrossRefGoogle Scholar
  5. Cassady JM, Douros JD (1980) Miscellaneous natural products with antitumor activity. Anticancer agents based on natural product models. Academic, New YorkGoogle Scholar
  6. Choi YH, Kang HS, Yoo MA (2003) Suppression of human prostate cancer cell growth by beta-lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21(WAF1/CIP1). J Biochem Mol Biol 36(2):223–229PubMedGoogle Scholar
  7. Coelho JM, Antoniolli AB, Nunes e Silva D, Carvalho TM, Pontes ER, Odashiro AN (2010) Effects of silver sulfadiazine, ipê roxo (Tabebuia avellanedae) extract and barbatimão (Stryphnodendron adstringens) extract on cutaneous wound healing in rats. Rev Col Bras Cir 37(1):45–51. PortugueseCrossRefGoogle Scholar
  8. Costa WF, Oliveira AB, Nepomuceno JC (2011) Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wts. Genet Mol Res 10(4):3236–3245CrossRefGoogle Scholar
  9. Cragg GM, Newman DJ (2005) Plants as a source of anticancer agents. J Ethnopharmacol 100:72.79CrossRefGoogle Scholar
  10. de Cássia da Silveira ESR, de Oliveira GM (2007) Reproductive toxicity of lapachol in adult male Wistar rats submitted to short-term treatment. Phytother Res 21(7):658–662CrossRefGoogle Scholar
  11. de Melo JG, Santos AG, de Amorim EL, do Nascimento SC, de Albuquerque UP (2011) Medicinal plants used as antitumor agents in Brazil: an ethnobotanical approach. Evid Based Complement Alternat Med:365359. http://doi.org/10.1155/2011/365359 CrossRefGoogle Scholar
  12. de Miranda FG, Vilar JC, Alves IA, Cavalcanti SC, Antoniolli AR (2001) Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacol 1:6CrossRefGoogle Scholar
  13. de Oliveira AB, Raslan DS, de Oliveira GG, Maia JGS (1993) Lignans and naphthoquinones from Tabebuia incana. Phytochemistry 34:1409–1412CrossRefGoogle Scholar
  14. de Santana CF, de Lima OG, d’ Albuquerque IL, Lacerda AL, Martins DG (1968) Antitumoral and toxicological properties of extracts of bark and various wood components of Pau d’arco (Tabebuia avellanedae). Rev Inst Antibiot (Recife) 8(1):89–94. PortugueseGoogle Scholar
  15. de Sousa NC, de Rezende AA, da Silva RM, Guterres ZR, Graf U, Kerr WE, Spanó MA (2009) Modulatory effects of Tabebuia impetiginosa (Lamiales, Bignoniaceae) on doxorubicin-induced somatic mutation and recombination in Drosophila melanogaster. Genet Mol Biol 32(2):382–388CrossRefGoogle Scholar
  16. de Walt S (1995) Collection #160. Herbarium specimen label data, available online at http://www.tropicos.org/Specimen/1323429. MBG, St. Louis, 1995
  17. Duke J (1985) CRC Handbook of medicinal herbs. CRC Press, Boca RatónGoogle Scholar
  18. Duke J, Vasquez R (1994) Amazonian ethnobotanical dictionary. CRC Press, Ann ArborGoogle Scholar
  19. FDA (1999) Econimuc characterization of the dietary supplement industry. Final Report. US FDA, Washington, DC 1999Google Scholar
  20. Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, Jacinto J, Veronezi PO, Pizzolatti MG, Rodrigues AL (2010) Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system. Prog Neuro-Psychopharmacol Biol Psychiatry 34(2):335–343CrossRefGoogle Scholar
  21. Freitas AE, Machado DG, Budni J, Neis VB, Balen GO, Lopes MW, de Souza LF, Veronezi PO, Heller M, Micke GA, Pizzolatti MG, Dafre AL, Leal RB, Rodrigues AL (2013) Antidepressant-like action of the bark ethanolic extract from Tabebuia avellanedae in the olfactory bulbectomized mice. J Ethnopharmacol 145(3):737–745CrossRefGoogle Scholar
  22. Garcia-Barriga H (1975) Flora medicinal de Colombia Tomo 3. Instituto de Ciencias Naturales, Bogota, pp 142–148Google Scholar
  23. Garkavtsev I, Chauhan VP, Wong HK, Mukhopadhyay A, Glicksman MA, Peterson RT, Jain RK (2011) Dehydro-alpha-lapachone, a plant product with antivascular activity. Proc Natl Acad Sci U S A 108(28):11596–11601CrossRefGoogle Scholar
  24. Gentry A (1992) A synopsis of Bignoniaceae ethnobotany and economic botany. Ann Miss Bot Gard 79(1):53–64CrossRefGoogle Scholar
  25. Gómez Castellanos JR, Prieto JM, Heinrich M (2009) Red Lapacho (Tabebuia impetiginosa) – a global ethnopharmacological commodity? J Ethnopharmacol 121(1):1–13CrossRefGoogle Scholar
  26. González-Coloma A, Reina M, Sáenz C, Lacret R, Ruiz-Mesia L, Arán VJ, Sanz J, Martínez-Díaz RA (2012) Antileishmanial, antitrypanosomal, and cytotoxic screening of ethnopharmacologically selected Peruvian plants. Parasitol Res 110(4):1381–1392CrossRefGoogle Scholar
  27. Grenand P, Moretti C, Jacquemin H, Prévost M (2004) Pharmacopées Traditionnelles en Guyane: Créoles, Wayãpi, Palikur. IRD Éditions, ParisCrossRefGoogle Scholar
  28. Grose SO, Olmstead RG (2007) Taxonomic revisions in the polyphyletic genus Tabebuia s.l. (Bignoniaceae). Syst Bot 32(3):660–670CrossRefGoogle Scholar
  29. Higa RA, Aydos RD, Silva IS, Ramalho RT, Souza AS (2011) Study of the antineoplastic action of Tabebuia avellanedae in carcinogenesis induced by azoxymethane in mice. Acta Cir Bras 26(2):125–128CrossRefGoogle Scholar
  30. Höfling JF, Anibal PC, Obando-Pereda GA, Peixoto IA, Furletti VF, Foglio MA, Gonçalves RB (2010) Antimicrobial potential of some plant extracts against CaIndida species. Braz J Biol 70(4):1065–1068CrossRefGoogle Scholar
  31. Inagaki R, Ninomiya M, Tanaka K, Watanabe K, Koketsu M (2013) Synthesis and cytotoxicity on human leukemia cells of furonaphthoquinones isolated from Tabebuia plants. Chem Pharm Bull (Tokyo) 61(6):670–673CrossRefGoogle Scholar
  32. Jones K (1995) Pau d’Arco: Immune power from the rain forest. Healing Arts Press, RochesterGoogle Scholar
  33. Kiage-Mokua BN, Roos N, Schrezenmeir J (2012) Lapacho tea (Tabebuia impetiginosa) extract inhibits pancreatic lipase and delays postprandial triglyceride increase in rats. Phytother Res 26(12):1878–1883CrossRefGoogle Scholar
  34. Kim SO, Kwon JI, Jeong YK, Kim GY, Kim ND, Choi YH (2007) Induction of Egr-1 is associated with anti-metastatic and anti-invasive ability of beta-lapachone in human hepatocarcinoma cells. Biosci Biotechnol Biochem 71(9):2169–2176CrossRefGoogle Scholar
  35. Kim MG, Jeon JH, Lee HS (2013) Larvicidal activity of the active constituent isolated from Tabebuia avellanedae bark and structurally related derivatives against three mosquito species. J Agric Food Chem 61(45):10741–10745CrossRefGoogle Scholar
  36. Koyama J, Morita I, Kino A, Tagahara K (2000a) Micellar electrokinetic chromatography (MEKC) separation of furanonaphthoquinones from Tabebuia impetiginosa. Chem Pharm Bull (Tokyo) 48(6):873–875CrossRefGoogle Scholar
  37. Koyama J, Morita I, Tagahara K, Hirai K (2000b) Cyclopentene dialdehydes from Tabebuia impetiginosa. Phytochemistry 53(8):869–872CrossRefGoogle Scholar
  38. Kreher B, Lotter H, Cordell GA, Wagner H (1988) New Furanonaphthoquinones and other Constituents of Tabebuia avellanedae and their immunomodulating activities in vitro. Planta Med 54(6):562–563CrossRefGoogle Scholar
  39. Kung HN, Yang MJ, Chang CF, Chau YP, Lu KS (2008) In vitro and in vivo wound healing-promoting activities of beta-lapachone. Am J Phys Cell Phys 295(4):C931–C943CrossRefGoogle Scholar
  40. Lamberti MJ, Vittar NB, da Silva Fde C, Ferreira VF, Rivarola VA (2013) Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 20(11):1007–1012CrossRefGoogle Scholar
  41. Lee JH, Cheong J, Park YM, Choi YH (2005) Down-regulation of cyclooxygenase-2 an telomerase activity by beta-lapachone in human prostate carcinoma cells. Pharmacol Res 51(6):553–560CrossRefGoogle Scholar
  42. Lee JI, Choi DY, Chung HS, Seo HG, Woo HJ, Choi BT, Choi YH (2006) Beta- lapachone induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2 family and activation of caspases. Exp Oncol 28(1):30–35PubMedGoogle Scholar
  43. Lee MH, Choi HM, Hahm DH, Her E, Yang HI, Yoo MC, Kim KS (2012) Analgesic and anti-inflammatory effects in animal models of an ethanolic extract of Taheebo, the inner bark of Tabebuia avellanedae. Mol Med Rep 6(4):791–796CrossRefGoogle Scholar
  44. Lee S, Kim IS, Kwak TH, Yoo HH (2013) Comparative metabolism study of β- lapachone in mouse, rat, dog, monkey, and human liver microsomes using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 83:286–292CrossRefGoogle Scholar
  45. Lemos TL, Monte FJ, Santos AK, Fonseca AM, Santos HS, Oliveira MF, Costa SM, Pessoa OD, Braz-Filho R (2007) Quinones from plants of northeastern Brazil: structural diversity, chemical transformations, NMR data and biological activities. Nat Prod Res 21(6):529–550CrossRefGoogle Scholar
  46. Lemos OA, Sanches JC, Silva IE, Silva ML, Vinhólis AH, Felix MA, Santos RA, Cecchi AO (2012) Genotoxic effects of Tabebuia impetiginosa (Mart. Ex DC.) Standl. (Lamiales, Bignoniaceae) extract in Wistar rats. Genet Mol Biol 35(2):498–502CrossRefGoogle Scholar
  47. Macedo L, Fernandes T, Silveira L, Mesquita A, Franchitti AA, Ximenes EA (2013) β-Lapachone activity in synergy with conventional antimicrobials against methicillin resistant Staphylococcus aureus strains. Phytomedicine 21(1):25–29CrossRefGoogle Scholar
  48. Machado TB, Pinto AV, Pinto MC, Leal IC, Silva MG, Amaral AC, Kuster RM, Netto-dos Santos KR (2003) In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin- resistant Staphylococcus aureus. Int J Antimicrob Agents 21(3):279–284CrossRefGoogle Scholar
  49. Melo e Silva F, de Paula JE, Espindola LS (2009) Evaluation of the antifungal potential of Brazilian Cerrado medicinal plants. Mycoses 52(6):511–517CrossRefGoogle Scholar
  50. Menna-Barreto RF, Henriques-Pons A, Pinto AV, Morgado-Diaz JA, Soares MJ, De Castro SL (2005) Effect of a beta-lapachone-derived naphthoimidazole on Trypanosoma cruzi: identification of target organelles. J Antimicrob Chemother 56(6):1034–1041CrossRefGoogle Scholar
  51. Moon DO, Kang CH, Kim MO, Jeon YJ, Lee JD, Choi YH, Kim GY (2010) Beta-lapachone (LAPA) decreases cell viability and telomerase activity in leukemia cells: suppression of telomerase activity by LAPA. J Med Food 13(3):481–488CrossRefGoogle Scholar
  52. Moreira Vasconcelos C, Chaves Vasconcelos TL, Póvoas FTX, Evangelista Pires dos Santos RF, da Costa Maynart WH, Gomes de Almeida T, da Silva Oliveira JF, Dalboni França AD, Sales Santos Veríssimo RC, Lins TH, de Araújo-Júnior JX, de Assis Bastos ML (2014) Antimicrobial, antioxidant and cytotoxic activity of extracts of Tabebuia impetiginosa (Mart. ex DC.) Standl. J Chem Pharm Res 6(7):2673–2681Google Scholar
  53. Mukherjee B, Telang N, Wong GY (2009) Growth inhibition of estrogen receptor positive human breast cancer cells by Taheebo from the inner bark of Tabebuia avellandae tree. Int J Mol Med 24(2):253–260PubMedGoogle Scholar
  54. Muñoz V, Sauvain M, Bourdy G, Callapa J, Rojas I, Bergeron S, Rojas I, Bravo J, Balderrama L, Ortiz B, Gimenez A, Deharo E (2000) A search for natural bioactive compounds through a multidisciplinary approach in Bolivia. Part I. Evaluation of the antimalarial activity of some plants used by Chacobo Indians. J Ethnopharmacol 69:127–137CrossRefGoogle Scholar
  55. Park BS, Lee KG, Shibamoto T, Lee SE, Takeoka GR (2003) Antioxidant activity and characterization of volatile constituents of Taheebo (Tabebuia impetiginosa Martius ex DC). J Agric Food Chem 51(1):295–300CrossRefGoogle Scholar
  56. Park BS, Lee HK, Lee SE, Piao XL, Takeoka GR, Wong RY, Ahn YJ, Kim JH (2006) Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol 105(1–2):255–262CrossRefGoogle Scholar
  57. Pereira EM, Machado Tde B, Leal IC, Jesus DM, Damaso CR, Pinto AV, Giambiagi-de Marval M, Kuster RM, Santos KR (2006) Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann Clin Microbiol Antimicrob 5:5CrossRefGoogle Scholar
  58. Pereira IT, Burci LM, da Silva LM, Baggio CH, Heller M, Micke GA, Pizzolatti MG, Marques MC, Werner MF (2013) Antiulcer effect of bark extract of Tabebuia avellanedae: activation of cell proliferation in gastric mucosa during the healing process. Phytother Res 27(7):1067–1073CrossRefGoogle Scholar
  59. Pertino MW, Theoduloz C, Palenzuela JA, Afonso Mdel M, Yesilada E, Monsalve F, González P, Droguett D, Schmeda-Hirschmann G (2011) Synthesis and pharmacological activity of diterpenylnaphthoquinone derivatives. Molecules 16(10):8614–8628CrossRefGoogle Scholar
  60. Plowman T (1967) Collection #126. Herbarium specimen label data, available online at http://www.tropicos.org/Specimen/1048249. MBG, St. Louis, 1967
  61. Queiroz ML, Valadares MC, Torello CO, Ramos AL, Oliveira AB, Rocha FD, Arruda VA, Accorci WR (2008) Comparative studies of the effects of Tabebuia avellanedae bark extract and beta-lapachone on the hematopoietic response of tumour- bearing mice. J Ethnopharmacol 117(2):228–235CrossRefGoogle Scholar
  62. Rodrigues E (2006) Plants and animals utilized as medicines in the Jaú National Park (JNP), Brazilian Amazon. Phytother Res 20:378–391CrossRefGoogle Scholar
  63. Schultes RE, Raffauf RF (1990) The healing forest. Dioscorides Press, Portland, pp 107–109Google Scholar
  64. Schunke J (1993) Collection #14378. Herbarium specimen label data, available online at http://www.tropicos.org/Specimen/2996041. MBG, St. Louis. 1993
  65. Silva TM, Da Silva TG, Martins RM, Maia GL, Cabral AG, Camara CA, Agra MF, Barbosa-Filho JM (2007) Molluscicidal activities of six species of Bignoniaceae from north-eastern Brazil, as measured against Biomphalaria glabrata under laboratory conditions. Ann Trop Med Parasitol 101(4):359–365CrossRefGoogle Scholar
  66. Steinert J, Khalaf H, Rimpler M (1995) HPLC separation and determination of naphthol[2,3-b]furan-4,9-diones and related compounds in extracts of Tabebuia avellanedae (Bignoniaceae). J Chromatogr A693:281–287CrossRefGoogle Scholar
  67. Steinert J, Khalaf H, Rimpler M (1996) High-performance liquid chromatographic separation of some naturally occurring naphthoquinones and anthraquinones. J Chromatogr A723:206–209CrossRefGoogle Scholar
  68. Suo M, Isao H, Kato H, Takano F, Ohta T (2012) Anti-inflammatory constituents from Tabebuia avellanedae. Fitoterapia 83(8):1484–1488CrossRefGoogle Scholar
  69. Suo M, Ohta T, Takano F, Jin S (2013) Bioactive phenylpropanoid glycosides from Tabebuia avellanedae. Molecules 18(7):7336–7345CrossRefGoogle Scholar
  70. Taylor L (2005) The healing power of rainforest herbs. Square One Publishers, Garden Park CityGoogle Scholar
  71. Thomson RH (1971) Naphthaquinones. Naturally occurring quiones, vol 203. Academic, LondonGoogle Scholar
  72. Twardowschy A, Freitas CS, Baggio CH, Mayer B, dos Santos AC, Pizzolatti MG, Zacarias AA, dos Santos EP, Otuki MF, Marques MC. Antiulcerogenic activity of bark extract of Tabebuia avellanedae, Lorentz ex Griseb. J Ethnopharmacol. 2008;118(3):455–459CrossRefGoogle Scholar
  73. Warashina T, Nagatani Y, Noro T (2004) Constituents from the bark of Tabebuia impetiginosa. Phytochemistry 65(13):2003–2011CrossRefGoogle Scholar
  74. Warashina T, Nagatani Y, Noro T (2005) Further constituents from the bark of Tabebuia impetiginosa. Phytochemistry 66(5):589–597CrossRefGoogle Scholar
  75. Warashina T, Nagatani Y, Noro T (2006) Constituents from the bark of Tabebuia impetiginosa. Chem Pharm Bull (Tokyo) 54(1):14–20CrossRefGoogle Scholar
  76. Woo HJ, Choi YH (2005) Growth inhibition of A549 human lung carcinoma cells by beta-lapachone through induction of apoptosis and inhibition of telomerase activity. Int J Oncol 26(4):1017–1023PubMedGoogle Scholar
  77. Woo HJ, Park KY, Rhu CH, Lee WH, Choi BT, Kim GY, Park YM, Choi YH (2006) Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase. J Med Food 9(2):161–168CrossRefGoogle Scholar
  78. Xu J, Wagoner G, Douglas JC, Drew PD (2013) β-Lapachone ameliorization of experimental autoimmune encephalomyelitis. J Neuroimmunol 254(1–2):46–54CrossRefGoogle Scholar
  79. Yamashita M, Kaneko M, Iida A, Tokuda H, Nishimura K (2007) Stereoselective synthesis and cytotoxicity of a cancer chemopreventive naphthoquinone from Tabebuia avellanedae. Bioorg Med Chem Lett 17(23):6417–6420CrossRefGoogle Scholar
  80. Yamashita M, Kaneko M, Tokuda H, Nishimura K, Kumeda Y, Iida A (2009) Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae. Bioorg Med Chem 17(17):6286–6291CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Ilia State University, Institute of Botany and Bakuriani Alpine Botanical Garden, Department of EthnobotanyTbilisiGeorgia

Personalised recommendations